FreeOx closes EUR500,000 round to accelerate stroke drugs
FreeOx Biotech, a spin-out of Hospital Clinic Barcelona-IDIBAPS which is developing a new class of neuroprotective drugs, has closed its first round of funding with EUR500,000 from private investors Montserrat Esteve and Francisco Javier Alsina. The biotechnology firm has two highly promising molecules in its pipeline to treat stroke and
